Copegus

Copegus is a brand name of ribavirin, approved by the FDA in the following formulation(s):

COPEGUS (ribavirin - tablet; oral)

• 
  Manufacturer: ROCHE
  
  Approval date: December 3, 2002
  
  Strength(s): 200MG ^[AB]

Has a generic version of Copegus been approved?

A generic version of Copegus has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Copegus and have been approved by the FDA:

ribavirin tablet; oral

• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: September 17, 2009
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: October 3, 2006
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: December 5, 2005
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: THREE RIVERS PHARMS
  
  Approval date: December 5, 2005
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA
  
  Approval date: December 5, 2005
  
  Strength(s): 200MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Copegus. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Copegus.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • August 9, 2014 - NEW PATIENT POPULATION
  
  

See also...

• Copegus Consumer Information (Wolters Kluwer)
• Copegus Consumer Information (Cerner Multum)
• Copegus Advanced Consumer Information (Micromedex)
• Ribavirin Consumer Information (Wolters Kluwer)
• Ribavirin Capsules Consumer Information (Wolters Kluwer)
• Ribavirin Solution Consumer Information (Wolters Kluwer)
• Ribavirin Consumer Information (Cerner Multum)
• Ribasphere Ribapak Advanced Consumer Information (Micromedex)
• Ribavirin Advanced Consumer Information (Micromedex)
• Ribavirin Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Ribavirin AHFS DI Monographs (ASHP)